| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |